SUBSCRIBE
SUBSCRIBE

Revalesio

IN THE PRESS
Drug Development
FDA Grants Revalesio Orphan Drug Status For Als Investigational Drug RNS60
September 22, 2017
 · 
3 min read
Biotech Beach
Revalesio Expands FANTOM II Clinical Trial To Europe
April 23, 2015
 · 
3 min read
BioForest
Revalesio’s RNS60 Demonstrates Promise In Treating Alzheimer’s Disease And Other Dementias
October 20, 2014
 · 
4 min read
Business
Revalesio Names Bert van den Bergh President
October 20, 2014
 · 
2 min read
BioForest
Revalesio Presents Update On The Development Of RNS60 As A Therapeutic For Acute Heart Disease At The American Heart Association Scientific Sessions
November 18, 2013
 · 
2 min read
Drug Development
Revalesio Initiates Phase IIa Study of RNS60 in Multiple Sclerosis at University Hospital Zurich
November 11, 2013
 · 
3 min read
BioForest
Mouse Model of Parkinson’s Disease Shows Improved Brain Function, Motor Skills Due to Revalesio’s RNS60
October 17, 2013
 · 
3 min read
Drug Development
Revalesio Presents Data Showing RNS60 Alters Disease Progression in Animal Model of Alzheimer’s Disease Through the PI3k-Akt Pathway
July 18, 2013
 · 
2 min read
Drug Development
Revalesio’s RNS60 Protects Myelin and Halts Multiple Sclerosis in Mice
January 3, 2013
 · 
3 min read
Drug Development
Revalesio’s RNS60 Demonstrates Promise in First Human Asthma Trial
October 31, 2011
 · 
2 min read
Load More
JOBS